Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
56.14 EUR | -2.37% | -5.68% | -4.82% |
Apr. 24 | CAC40: interest rates soar, pulling back below 8100 pts | CF |
Apr. 24 | EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed |
Business Summary
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Number of employees: 61,798
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sample-based
82.7
%
| 5,588 | 83.3 % | 5,388 | 82.7 % | -3.59% |
Study-based
8.3
%
| 572 | 8.5 % | 541 | 8.3 % | -5.37% |
Full Time Equivalent-based
6.9
%
| 426 | 6.4 % | 449 | 6.9 % | +5.28% |
Product-based
2.1
%
| 126 | 1.9 % | 137 | 2.1 % | +8.73% |
Other
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +100.00% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
50.8
%
| 3,507 | 52.2 % | 3,306 | 50.8 % | -5.72% |
North America
38.5
%
| 2,494 | 37.2 % | 2,507 | 38.5 % | +0.52% |
Rest of the World
10.8
%
| 711 | 10.6 % | 701 | 10.8 % | -1.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 14-12-31 |
Christian Wurst
COO | Chief Operating Officer | - | 19-09-30 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 91-12-31 |
François Vigneau
PRN | Corporate Officer/Principal | 58 | 96-10-31 |
Corporate Officer/Principal | 41 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 91-12-31 |
Valérie Hanote
BRD | Director/Board Member | 58 | 90-12-31 |
Director/Board Member | 69 | 14-04-23 | |
Director/Board Member | 60 | 17-04-19 | |
Evie Roos
BRD | Director/Board Member | 56 | - |
Pascal Rakovsky
BRD | Director/Board Member | 65 | 20-05-31 |
Ivo Rauh
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 192,981,183 | 128,871,845 ( 66.78 %) | 955,858 ( 0.4953 %) | 66.78 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
EUROFINS CEREP 95.76% | 4,831 | 95.76% | 120,002,043 $ |
EUROFINS SCIENTIFIC SE 0.50% | 955,858 | 0.50% | 60,989,858 $ |
VIMTA LABS LIMITED 19.86% | 4,403,668 | 19.86% | 23,474,985 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Wiener Neudorf Palmersstraße Real Estate GmbH
| |
Eurofins GeneScan Holding GmbH
Eurofins GeneScan Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins GeneScan Holding GmbH is a world leader in food, environment, pharma product testing & agroscience CRO services. The private company is based in Freiburg im Breisgau, Germany. With a network of more than 1,000 independent companies (900 laboratories) in 61 countries, Eurofins GeneScan Holding offers over 200,000 analytical methods. The CEO of the German company is Gilles G. Martin. |
Miscellaneous Commercial Services
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.88% | 11.88B | |
-14.73% | 84.87B | |
+16.05% | 83.08B | |
+10.92% | 29.4B | |
-12.73% | 16.72B | |
-3.67% | 16.4B | |
-1.78% | 15.04B | |
+0.03% | 11.88B | |
-31.40% | 11.86B | |
+26.74% | 11.64B |
- Stock Market
- Equities
- ERF Stock
- Company Eurofins Scientific SE